John Ryan, MD, Ph.D.

Executive Vice President, Chief Medical Officer at Kadmon

Dr. Ryan, Ph.D., MD, is Executive Vice President, Chief Medical Officer at Kadmon. Dr. Ryan has more than 20 years of experience in drug discovery and development, including expertise in translational medicine and cancer biology. Before joining Kadmon, he was Chief Medical Officer and Senior Vice President of Cerulean Pharma, Inc. from March 2010 and Acting Chief Medical Officer of Cerulean from July 2009 to March 2010. Dr. Ryan held the role of Chief Medical Officer at Aveo Pharmaceuticals, Inc. beginning in April 2006. Prior to Aveo, he served as Senior Vice President of Translational Research at Wyeth (formerly Genetics Institute). At Wyeth, he served as head of the new Department of Experimental Medicine, which was created to explore new technologies, such as pharmacogenomics, in exploratory clinical trials, to work closely with the FDA on clinical pharmacogenomics, and to bridge discovery and development with the creation of new biomarkers. Dr. Ryan served as an Executive Director of Clinical Research at Merck Research Laboratories. He served as Member of the Scientific Advisory Board of Arqule, Inc. and as Member of the Scientific Advisory Board of Expression Analysis, Inc. He was a Professor in the Department of Internal Medicine at Pennsylvania School of Medicine and Yale University School of Medicine from 1977 to 1989. Dr. Ryan received his bachelor’s degree from Yale University. He holds a Ph.D. in Molecular Biophysics from Yale University and an MD from the University of California.